These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 854880)

  • 1. The relationship between shape change and release reaction of lectin-stimulated platelets. Effects of cytochalasin B and prostaglandin E1.
    Patscheke H; Wörner P; Brossmer R
    Thromb Res; 1977 Mar; 10(3):465-74. PubMed ID: 854880
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet activation detected by turbidometric shape-change analysis: differential influence of cytochalasin B and prostaglandin E1.
    Patscheke H; Wörner P
    Thromb Res; 1978 Mar; 12(3):485-96. PubMed ID: 418518
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction of wheat germ agglutinin with human platelets: a model for studying platelet response.
    Rendu F; Lebret M
    Thromb Res; 1984 Dec; 36(5):447-56. PubMed ID: 6441308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for multiple mechanisms of interaction between wheat germ agglutinin and human platelets.
    Ganguly P; Fossett NG
    Biochim Biophys Acta; 1980 Feb; 627(3):256-61. PubMed ID: 6766328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common activation of aggregation and released reaction of platelets.
    Patscheke H; Wörner P
    Thromb Res; 1977 Sep; 11(3):391-402. PubMed ID: 411193
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential effects of cytochalasin B on platelet release, aggregation and contractility: evidence against a contractile mechanism for the release of platelet granular contents.
    Kirkpatrick JP; McIntire LV; Moake JL; Cimo PL
    Thromb Haemost; 1980 Feb; 42(5):1483-9. PubMed ID: 6892735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of platelet cyclic nucleotide content by PGE1 and the prostaglandin endoperoxide PGG2.
    Miller OV; Gorman RR
    J Cyclic Nucleotide Res; 1976; 2(2):79-87. PubMed ID: 177467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochalasin B, the blood platelet release reaction and cyclic GMP.
    Haslam RJ; Davidson MM; McClenaghan MD
    Nature; 1975 Feb; 253(5491):455-7. PubMed ID: 163012
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
    Eggerman TL; Harker LA; Andersen NH; Wilson CH
    Adv Prostaglandin Thromboxane Res; 1980; 6():389-93. PubMed ID: 6247888
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of collagen, ionophore A23187 and prostaglandin E1 on the phosphorylation of specific proteins in blood platelets.
    Haslam RJ; Lynham JA; Fox JE
    Biochem J; 1979 Feb; 178(2):397-406. PubMed ID: 375934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets.
    Salzman EW
    Biochim Biophys Acta; 1977 Aug; 499(1):48-60. PubMed ID: 196670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet interaction with bacteria. IV. Stimulation of the release reaction.
    Clawson CC; Rao GH; White JG
    Am J Pathol; 1975 Nov; 81(2):411-20. PubMed ID: 811123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of insulin on calcium metabolism and platelet aggregation.
    Ishida M; Ishida T; Ono N; Matsuura H; Watanabe M; Kajiyama G; Kambe M; Oshima T
    Hypertension; 1996 Aug; 28(2):209-12. PubMed ID: 8707383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of prostaglandins E1 and E2 on thrombocyte form and aggregation].
    Antonikov IM; Alekseev OV; Chernukh AM
    Biull Eksp Biol Med; 1982 Apr; 93(4):11-3. PubMed ID: 6952942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-Keto-prostaglandin E1 inhibits the aggregation of human platelets.
    Wong PY; McGiff JC; Sun FF; Lee WH
    Eur J Pharmacol; 1979 Dec; 60(2-3):245-8. PubMed ID: 393526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of prostaglandin G2 on platelet ultrastructure and platelet secretion.
    Gerrard JM; Townsend D; Stoddard S; Witkop CJ; White JG
    Am J Pathol; 1977 Jan; 86(1):99-116. PubMed ID: 188341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased phosphorylation of specific blood platelet proteins in association with the release reaction.
    Haslam RJ; Lynham JA
    Biochem Soc Trans; 1976; 4(4):694-7. PubMed ID: 187490
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship of ADP-induced fibrinogen binding to platelet shape change and aggregation elucidated by use of colchicine and cytochalasin B.
    Peerschke EI; Zucker MB
    Thromb Haemost; 1980 Feb; 43(1):58-60. PubMed ID: 7404479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between phosphorylation of blood platelet proteins and secretion of platelet granule constituents II. Effects of different inhibitors.
    Haslam RJ; Lynham JA
    Thromb Res; 1978 Apr; 12(4):619-28. PubMed ID: 208190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.